Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (101)	1/1/2000 8:52:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 360

Race to Decode Human Genome as Volatile as Biotech Stocks By Carolyn Marshall nextwavestocks.com “I'm at a loss to understand why people are upset with Celera,” said Stephen Push, Celera's new director of investor relations. By the way, I checked to see what my 1999 picks would have done if I'd left them unattended...+220%, so I paid a 40% penalty for churning this past year. As far as missing out on this one--I'm sure you saw my message on the nifty thread, well, it is unlikely I'd have stayed concentrated in the three picks that I happened to hold in August--and they'd only have bought me an extra ten or 20%. So that is not so bad. Best of luck for 2000! My New Years resolutions include limiting to one post a day, an hour on the net for every two hours reading (some of that is looking at meteorologic numerical model solutions, so less room for the biotech hobby for sure) and I'll be recording all my thoughts for trades in a diary--I think that will help reduce the churn. The lobster bisque, the smoked salmon, the lamb, the mousse--I think I'm finally through digesting most of the New Years Eve meal--maybe now I can go back to sleep--but did not drink anything besides sparkling Mount Rainier glacier water--that helps.